Leadership Overview
Revvity has 6 executives leading key functions including finance, information technology, diagnostics, life sciences, and software.
Driven by innovation, Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure, impacting global health outcomes.
Driven by innovation, Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure, impacting global health outcomes.
Leadership Roles at Revvity
Maxwell Krakowiak - Senior Vice President & Chief Financial Officer
Maxwell Krakowiak, the Senior Vice President & Chief Financial Officer at Revvity, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Krakowiak ensures robust financial health across the organization. This leadership role involves managing capital allocation, investor relations, and driving profitability through disciplined financial management. By optimizing financial strategies, Maxwell Krakowiak directly supports Revvity's mission to deliver comprehensive health science solutions. The Chief Financial Officer's oversight extends to risk management and ensuring compliance with all financial regulations, thereby safeguarding the company's assets and enhancing shareholder value. Krakowiak's expertise is critical in navigating complex market dynamics and securing resources for future growth and development initiatives.

Oswaldo Garcia - Diagnostics Vice President & Chief Financial Officer
Oswaldo Garcia, the Diagnostics Vice President & Chief Financial Officer at Revvity, spearheads financial strategy and operations specifically for the diagnostics division. Garcia manages the financial health and performance of this key business segment, ensuring alignment with Revvity's broader mission. This role involves detailed financial planning, P&L management, and resource allocation to drive growth and innovation within diagnostics. By providing critical financial insights, Oswaldo Garcia supports the development and delivery of diagnostic solutions that advance patient care. The Chief Financial Officer's focus is on optimizing profitability and operational efficiency within the diagnostics portfolio. Garcia's financial acumen is essential for expanding market reach and ensuring the sustainable success of Revvity's diagnostic offerings globally.
Elvin Chen - Global Life Sciences Vice President & Chief Financial Officer
Elvin Chen, the Global Life Sciences Vice President & Chief Financial Officer at Revvity, leads financial strategy and execution for the life sciences sector. Chen is responsible for the financial performance and strategic fiscal direction of this vital business area, supporting end-to-end workflows from discovery to cure. This position demands rigorous financial oversight, including budgeting, investment analysis, and P&L management to foster innovation and market expansion. By ensuring sound financial practices, Elvin Chen enables the life sciences division to accelerate research and development efforts. The Chief Financial Officer's contribution is crucial for maximizing the impact of Revvity's life sciences solutions. Chen's financial leadership drives sustainable growth and strengthens Revvity's commitment to advancing scientific breakthroughs worldwide.
Shripad Joshi - President & Global General Manager, Southeast & - Esa Portfolio (, , South, Asia, Asia, Thailand, Vietnam)
Shripad Joshi, the President & Global General Manager, Southeast & - Esa Portfolio (, , South, Asia, Asia, Thailand, Vietnam) at Revvity, directs operations and strategic growth across a significant global region. Joshi oversees the comprehensive portfolio within Southeast Asia, including Thailand and Vietnam, driving business development and market penetration. This leadership position involves managing diverse teams and ensuring the effective delivery of Revvity's health science solutions throughout the specified territories. By fostering strong regional partnerships and understanding local market dynamics, Shripad Joshi enhances Revvity's presence and impact. The Global General Manager's focus is on achieving operational excellence and expanding market share. Joshi's strategic guidance is key to realizing Revvity's mission in these critical international markets.
Kevin Willoe - President, Revvity Signals Software
Kevin Willoe, the President, Revvity Signals Software at Revvity, leads the strategic direction and operational execution for the company's software division. Willoe drives the development and delivery of advanced software solutions that support critical workflows in health sciences, from research to clinical applications. This executive role involves overseeing product innovation, market strategy, and customer engagement to ensure the software portfolio meets evolving industry needs. By championing technological advancements, Kevin Willoe enhances Revvity's ability to provide integrated solutions. The President's leadership is vital for expanding the reach and impact of Revvity Signals Software. Willoe's expertise is instrumental in positioning the software offerings as industry-leading tools for scientific discovery and development.
Jayashree Thacker - Senior Vice President and Global Chief Information Officer
Jayashree Thacker, the Senior Vice President and Global Chief Information Officer at Revvity, architects the company's global technology strategy and digital infrastructure. Overseeing all aspects of information technology, Thacker drives innovation in systems and data management to support Revvity's comprehensive workflows. This critical role involves ensuring the security, scalability, and efficiency of IT operations worldwide, directly enabling seamless discovery to development and diagnosis to cure processes. By implementing advanced technological solutions, Jayashree Thacker enhances operational effectiveness and supports data-driven decision-making across all business units. The Chief Information Officer's leadership ensures that Revvity maintains a competitive technological edge, facilitating collaboration and accelerating scientific advancements. Thacker's strategic vision is paramount in transforming data into actionable insights that advance global health.

Explore Leadership Teams in Business Services
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIA has dual headquarters in Danbury Connecticut and Durham, North Carolina.
Company Leadership JR
AF
AM
Founded in 1984, SCS Global Services provides third-party environmental and sustainability certification, auditing, testing, and standards development services to clients in the United States and internationally. SCS is located in Emeryville, California.
Company Leadership
KG

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is to radically improve the lives of patients and industrialize drug discovery. Central to our mission is the Recursion Operating System, which combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets. We combine that with the Recursion Map, a suite of custom software, algorithms and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights.
Company Leadership DB
ML
Founded in 1999 and headquartered in Danvers, Massachusetts, Cell Signaling Technology is a life sciences company providing researchers with products and services that support scientific discovery. The company's products include; antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health.
Company Leadership CT
MC
RP